Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

NCT05087030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: RGB-14-P
DRUG: Prolia®

Sponsor

Gedeon Richter Plc.